Elevance Health, Inc.
ELV · NYSE
- $418.72
- $92.03B
- Open
- —
- —
- $420.28 - $427.17
- $274.84 - $436.24
- —
- —
- 1.12M
About Elevance Health, Inc.
Elevance Health sells health coverage and related healthcare services. Its Health Benefits business is the core operation, providing insurance products to employer, individual, Medicaid and Medicare customers and earning revenue primarily from premiums. Its Carelon businesses provide healthcare services, including pharmacy and care-delivery capabilities, and generate additional service-related revenue. Health Benefits contributes the overwhelming majority of consolidated revenue, while Carelon is smaller; the supplied evidence does not provide a segment split. Elevance reported $199.1 billion of FY2025 revenue and $5.7 billion of net income, compared with $177.0 billion and $6.0 billion, respectively, in FY2024.
Notable Price Movement
- Aug 3-7$394.204.89%
Elevance Health fell $7.73, or 2.00%, from $385.73 on July 28 to $378.00 on August 4. The main move was a $9.75 decline on July 29, after which the stock traded almost flat through July 31. It then recovered $6.93 on August 3 before giving back $4.77, or most of that rebound, on August 4. The supplied evidence contains no Elevance-specific announcement, earnings release, guidance change, analyst action, or contract news explaining the move. It also provides no identifiable market-wide catalyst, so the weekly decline appears to have occurred without a documented company-specific driver.
